Received: from BY2NAM01HT169.eop-nam01.prod.protection.outlook.com
 (2603:1096:a00:1::34) by MAXPR0101MB2074.INDPRD01.PROD.OUTLOOK.COM with HTTPS
 via MA1PR01CA0118.INDPRD01.PROD.OUTLOOK.COM; Sat, 3 Feb 2018 08:01:33 +0000
Received: from BY2NAM01FT064.eop-nam01.prod.protection.outlook.com
 (10.152.68.59) by BY2NAM01HT169.eop-nam01.prod.protection.outlook.com
 (10.152.68.81) with Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA384_P384) id 15.20.444.13; Sat, 3
 Feb 2018 08:01:30 +0000
Authentication-Results: spf=pass (sender IP is 144.217.109.84)
 smtp.mailfrom=oap-cancer.org; outlook.com; dkim=pass (signature was verified)
 header.d=oap-cancer.org;outlook.com; dmarc=bestguesspass action=none
 header.from=oap-cancer.org;
Received-SPF: Pass (protection.outlook.com: domain of oap-cancer.org
 designates 144.217.109.84 as permitted sender)
 receiver=protection.outlook.com; client-ip=144.217.109.84;
 helo=oh4.oap-cancer.org;
Received: from oh4.oap-cancer.org (144.217.109.84) by
 BY2NAM01FT064.mail.protection.outlook.com (10.152.69.129) with Microsoft SMTP
 Server id 15.20.444.13 via Frontend Transport; Sat, 3 Feb 2018 08:01:30 +0000
X-IncomingTopHeaderMarker: OriginalChecksum:A686B04A53D0A23A8EECC7984EA0A5459799067A1630FCB9F448CEB3AC3CB54D;UpperCasedChecksum:3EF7CD94013913C99E78CDC525834567DBA47F4B76010F5FB5C92673AD9B4F5E;SizeAsReceived:1441;Count:17
DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=k1; d=oap-cancer.org;
 h=To:Subject:Message-ID:Date:From:Reply-To:MIME-Version:List-Unsubscribe:Content-Type:Content-Transfer-Encoding; i=info@oap-cancer.org;
 bh=G3OVJ8edSEwT3YvkhFHYCMbwAac=;
 b=GrC0YRhdZVJYjsIlerjdIfv2RmHrtnh/uybjRRqz/N+dXPKPeOWKDKV+GQQys4xbCyAgC43gVIw4
   U+RcKM5k0U4BcLQQs7xfIs+Ed45lRi9Y1AHdKV4JC5gHA8X9OHsBGb0jvdp46i49fhX3ggo8ZzY8
   AxG/X7NtYN5hTcWlazU=
DomainKey-Signature: a=rsa-sha1; c=nofws; q=dns; s=k1; d=oap-cancer.org;
 b=WT3S8WmuoRrfoOZEmkAOicy/93eZodYjIeE+M7xOGGVw/NwXMDr7GpjI1ztknEBUxNtOK1UhzQgA
   M4ao0Y6aQm8fm3+tJtikXKcsoLrWtHJAK3DREJH7xkhLHeOZTe97WujBOsZ9m9nz4bAL5smZpADh
   0MCAAZ0/GVnYfA0qnPw=;
To: xiangzhen.kong@outlook.com
Subject: Make your research spread world wide by submitting your articles at International Journal of Negative Results with extravagant benefits. Last date: February 15, 2018
Message-ID: <60c2c64237ce78678b079646f4d9b1af@oap-cancer.org>
Return-Path: bounce@oap-cancer.org
Date: Fri, 02 Feb 2018 03:24:30 +0000
From: "IJNR" <info@oap-cancer.org>
Reply-To: info@oap-cancer.org
X-Mailer-LID: 80
List-Unsubscribe: <http://oap-cancer.org/cfp2/unsubscribe.php?M=3643070&C=&L=80&N=483>
X-Mailer-RecptId: 3643070
X-Mailer-SID: 483
X-Mailer-Sent-By: 3
Content-Type: multipart/alternative; charset="UTF-8"; boundary="b1_1148759d27530eb33e9fd06fdfffa2ff"
Content-Transfer-Encoding: 8bit
X-IncomingHeaderCount: 17
X-MS-Exchange-Organization-Network-Message-Id: 7095f993-0f73-421e-4d28-08d56adc55cc
X-EOPAttributedMessage: 0
X-EOPTenantAttributedMessage: 84df9e7f-e9f6-40af-b435-aaaaaaaaaaaa:0
X-MS-Exchange-Organization-MessageDirectionality: Incoming
X-Microsoft-Exchange-Diagnostics: 1;BY2NAM01FT064;1:gnd/CnqwCz8aTSJq2wQX53Lqt8gbz1hdT2WrgTm2gOHunbuMhg2UvM5gQpzyZ+mqep+h68o09khGrXvRbGa1/RgoOreb0m5XUhmwX5fSLOyitGTCkBFy9M6bVwtLURWM
X-Forefront-Antispam-Report: EFV:NLI;SFV:NSPM;SFS:(98901004);DIR:INB;SFP:;SCL:1;SRVR:BY2NAM01HT169;H:oh4.oap-cancer.org;FPR:;SPF:None;LANG:;
X-MS-Exchange-Organization-AuthSource: BY2NAM01FT064.eop-nam01.prod.protection.outlook.com
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-PublicTrafficType: Email
X-MS-Office365-Filtering-Correlation-Id: 7095f993-0f73-421e-4d28-08d56adc55cc
X-Microsoft-Antispam: BCL:0;PCL:0;RULEID:(5000109)(4604075)(4605076)(610169)(650170)(651021)(8291501071);SRVR:BY2NAM01HT169;
X-Microsoft-Exchange-Diagnostics: 1;BY2NAM01HT169;3:W7lpGN6vh0CQgKYeBuIPdxUXA/mZ79C7fTiUTIJH4RsAVs54SdOQFSe2pt/YuyWx/wRlTHLzroNN2EssKQLHbk1egHEuT6i8vdRPcg0Lsvf1r3DLJ+ji3x5kVu3IevRlQt4cR3Vo4H1/36i474qyfSNsOIQuYdWxuB7z6SNzDkGJGSvdgXDdVZIkMJzvKQSN17276jJ0dzts/ye0oesqNl01m7+DGCBRGX98rAAn7wtI5gwN8vBcrHbQKOaL7tqNf9yKN9KlTgLhngZqXqhnGtnCntWNAgJXL3r6kyIexx0rHH+kWvIlM6E5A0rcwMXW;25:RQuBnTa75V0+QA35C+HpB7CXirJfJbi1asH3VJ1s37DG+sB91bC+M1HTCuuE3QC6cn2VlAjKWk0owUJiTO3dKLbOoWidHrklrQ23gx+UW/XUrtNpp4ZXaVhjtaMwexaDYkQjA7cqZQwRmDOptLRCLyHD1eEoZ7JGQ+6hlcBa/SkjMmKXxlflWNlOMpiBM7xM+NJ1Zeo/KRw5+OeAZkNhJ1wFyhvxcy4UBOlSwL+Mjr+4Avs6YiOiGWeVKuZ2SawRLUYZDVcBSUy/QI8J3/RIUAul6oO6G2c8VN/76D2QSXhGn6FGx2ew2uMBzWwZefSb4xKM3WanG9FNpgR4WoawiQ==;31:mo7CKL+7ujJvF5pFWTlO9s1EgsBaEyEMptMzHgGOkubTJpRtoKmyHUyoeV+fne4frQPKsYf2Y9zojTyxb9lpmmmYN3HrsiIUrNkFVJ2Rt0C6+M2CJgVGg/p78zvhRIXkp9EZljJ6RlP7syY9lWNwZNwqg4LikjedqYT1MTsGXXVDeSvRZZw+/dR642P4Rd5qXtf3N75tksktAaXro/Qzx58790Td9L29I8IVkgEKTVE=
X-MS-TrafficTypeDiagnostic: BY2NAM01HT169:
X-MS-Exchange-EOPDirect: true
X-Sender-IP: 144.217.109.84
X-SID-PRA: INFO@OAP-CANCER.ORG
X-SID-Result: PASS
X-MS-Exchange-Organization-PCL: 2
X-Exchange-Antispam-Report-Test: UriScan:(209352067349851);
X-Exchange-Antispam-Report-CFA-Test: BCL:0;PCL:0;RULEID:(444111557)(2400082)(82015058);SRVR:BY2NAM01HT169;BCL:0;PCL:0;RULEID:;SRVR:BY2NAM01HT169;
X-Microsoft-Exchange-Diagnostics: 1;BY2NAM01HT169;4:efF6fj5nRVuKz2tPhzY6yD7056a65VL4NRvx3Zqhe5m7pb0VGeVk7gnkquf2x4N4iyE3lOkdMnuBtjmUwJizmNQt8ksr3HCGm/GKWOiSGroyQ/Lsl3fSc9QkbgoZxducH5Br+aAuGwAhxI5nYdJIFVKNB5pLIMvCzIp9HD2DOSFsn8unMoj5PBc1D4U6l0ubvmciKK0cNcZb65UsNG82ISjTWM48weNvIgSdi4fzICUwJatc/5GQxCW+LifRjs3mTqr5nwR1tAWgoFKQ0VpH2Z2K2Jj5fLW57R6xMhV0/9NMnIiiGYiasTPGT1V+6eCa;23:bRMLyEECM7XXFBOauK2Pn3nEUQolYYdw0Gmo1xjCK0nMFQjZLrvsllMxmdLZDF+ycIr9VzaZu/wF2PiIpmEwoK6SJrgtM/cnqYS/rKYdBHBa6x0PMoudXHFvSPZ8+wF9Z21Qt1XYEigm6oWLsnNcF9zR4KMf+GRoNqIxgoevJ9o=;6:kTEU+IcNJYfcKGZ95VOQE5l4upMAZGHEZ7HqqzwsjglnufV8wO/0HkVUf/GXsbFVUiwM8mvm+r9IXfZaZHDSsE98zXUqL0HHPmwkl1xqi8hk15a91XXWVTAjFyfcokHfIwz8gDgvT/EIAtoiwOLYoqEsVUlmBSCog6IR0PclS5CnQe0o3hBMIWlk+7M1X48WzDD+uq8REPkqMMF5uDmpBHN0AWI51+PcvdZ4nd+knSfYL6sV5RQvycMu9n+wWlv+k8PY81Z9Kc/9GRQa32vJsXwVy12eal6wpxaYnDNR8tGOLWUh9ZuPNjLbVb93+x1yKpzKCDKzbaHOuaZz0H4cGWrYHck2sIViIMyTwEANczs=
X-MS-Exchange-Organization-SCL: 1
X-Microsoft-Antispam-Message-Info: bOiKxHJuG4yac/opcCvKJBajUntsdK4sbl66HuWOrSVwl3r7y+CbIfWwuzCHkcRBcEF5qSH1UeyjTaAuDhpuNbaNkhWGCc6jKhsEZtepswo=
X-Microsoft-Exchange-Diagnostics: 1;BY2NAM01HT169;5:KOuF5aenhm8MoXtpLDNI00mcAosRq/haFZ82bs0eHYqmFC53gquvnHBQnTUOogt0thTC1qsFVY6q0d86IK7fn9pwEv9DAt2V9+vcF6VyDR+agIyjz5xIAfOXX7v98MHrmv+1x6MR3AixcDbPmg7ypC6PBXa1aTv0makcx8Vuyzs=;24:GNF+9ybfS3RueCUAdBtWrS9rTAvFlNcSOM6pGo7Ac3F+lOv5VQki+m+pVx/hDCLShnY99iV6Ua2wqOlRorOkoXPbqVwrh5A867CdZg3ue6Q=;7:fEQrYx/Y/a6hf/zrZSjQIfCZuiq6Bqkp7S/wlMW1KHrk2zuuEeUYpQD6lh5v/Qq+n7zeQdSameSoulcrMgx480yc9wM7xcLd8/lHp5Cm7GZvdaFG8Tk8Bt+ORww5EU3wpf+0BgMAkQOGLTRSE1Rx5Z39guC43YclbfQb6m4NxW+hYAnYtcwwhHPtkN4c2qRq1b8t4Nwnp1NAIJYZcZ8jjpQZ9NpNTLvCaQMrLINgfw7hGLPJnhNhdvdTwDVKJ1kA
SpamDiagnosticOutput: 1:99
SpamDiagnosticMetadata: NSPM
X-OriginatorOrg: outlook.com
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 03 Feb 2018 08:01:30.5876
 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: 7095f993-0f73-421e-4d28-08d56adc55cc
X-MS-Exchange-CrossTenant-Id: 84df9e7f-e9f6-40af-b435-aaaaaaaaaaaa
X-MS-Exchange-CrossTenant-FromEntityHeader: Internet
X-MS-Exchange-Transport-CrossTenantHeadersStamped: BY2NAM01HT169
X-MS-Exchange-Transport-EndToEndLatency: 00:00:03.2911845
X-MS-Exchange-Processed-By-BccFoldering: 15.20.0444.000
X-Microsoft-Exchange-Diagnostics:
	1;MAXPR0101MB2074;27:l4HdicTMorxMZZtz3RgaenxZRwEBXkziNmrcqToWYnbpUKNtQgnNBFuoDCWFWdvhK1TCppQjakTVfwYHKwk2mWyioQlK11W2BgACRbsW7rPoPkYvBCw35p7XyyrT6Nw9
X-Microsoft-Antispam-Mailbox-Delivery:
	abwl:0;wl:0;pcwl:0;kl:0;iwl:0;dwl:0;dkl:0;rwl:0;ex:0;auth:1;dest:J;ENG:(400001000128)(400125000095)(5062000261)(5061607266)(5061608174)(4900095)(4920089)(6375004)(4950112)(4990090)(9140004);RF:JunkEmail;OFR:SpamFilterAuthJ;
X-Message-Info:
	qoGN4b5S4ypJwnJu3iy0cITO4m4TF4G1iEJr/GiYirqQOvAOk0UD0WVgw5dQBZRVjO6+G/rLYenrurvYZN/4LKS0uJVQC6yiS6vrZ7TJ81ygDlgNeQGSYe03cXUbF6hs3V8hc5f1KPuMhiymubJxIB2Rf2KrCYQt7riTYUKykydZX3+3TbkvIu57rdWFBf156ug28TbMLYpvgME6ldPoew==
X-Message-Delivery: Vj0xLjE7dXM9MDtsPTA7YT0wO0Q9MjtHRD0yO1NDTD02
X-Microsoft-Antispam-Message-Info:
	SFGZnED32XPIgPtBMdFbeUfgtANq/DLxzJcssKqhL2ql4NnZnrvI0Tl64W8jYfD+RT9W8Ysw1yS9eIHt82/YLlfjoIz7vvjUm13ZAeu5HAjULDt5nU9Qg90U5P6cCuM0BK3oF7549IXyQgw7xk407UFHEASP2gTFeFV8Z+rZemqDnDgv9NI2hxMt+vLbIbSJUWDhV5ECVf1ZS4O/8WSzN30R9XmacM7+Wnw4rVC5OPztcgjYC3CjVs2mp9e36VwD6LTH0fuwXtdgpm5yxM7zDA==
MIME-Version: 1.0

--b1_1148759d27530eb33e9fd06fdfffa2ff
Content-Type: text/plain; format=flowed; charset="UTF-8"
Content-Transfer-Encoding: 8bit
X-Microsoft-Exchange-Diagnostics:
	1;MAXPR0101MB2074;27:l4HdicTMorxMZZtz3RgaenxZRwEBXkziNmrcqToWYnbpUKNtQgnNBFuoDCWFWdvhK1TCppQjakTVfwYHKwk2mWyioQlK11W2BgACRbsW7rPoPkYvBCw35p7XyyrT6Nw9
X-Microsoft-Antispam-Mailbox-Delivery:
	abwl:0;wl:0;pcwl:0;kl:0;iwl:0;dwl:0;dkl:0;rwl:0;ex:0;auth:1;dest:J;ENG:(400001000128)(400125000095)(5062000261)(5061607266)(5061608174)(4900095)(4920089)(6375004)(4950112)(4990090)(9140004);RF:JunkEmail;OFR:SpamFilterAuthJ;
X-Message-Info:
	qoGN4b5S4ypJwnJu3iy0cITO4m4TF4G1iEJr/GiYirqQOvAOk0UD0WVgw5dQBZRVjO6+G/rLYenrurvYZN/4LKS0uJVQC6yiS6vrZ7TJ81ygDlgNeQGSYe03cXUbF6hs3V8hc5f1KPuMhiymubJxIB2Rf2KrCYQt7riTYUKykydZX3+3TbkvIu57rdWFBf156ug28TbMLYpvgME6ldPoew==
X-Message-Delivery: Vj0xLjE7dXM9MDtsPTA7YT0wO0Q9MjtHRD0yO1NDTD02
X-Microsoft-Antispam-Message-Info:
	SFGZnED32XPIgPtBMdFbeUfgtANq/DLxzJcssKqhL2ql4NnZnrvI0Tl64W8jYfD+RT9W8Ysw1yS9eIHt82/YLlfjoIz7vvjUm13ZAeu5HAjULDt5nU9Qg90U5P6cCuM0BK3oF7549IXyQgw7xk407UFHEASP2gTFeFV8Z+rZemqDnDgv9NI2hxMt+vLbIbSJUWDhV5ECVf1ZS4O/8WSzN30R9XmacM7+Wnw4rVC5OPztcgjYC3CjVs2mp9e36VwD6LTH0fuwXtdgpm5yxM7zDA==

Your email client cannot read this email.
To view it online, please go here:
http://oap-cancer.org/cfp2/display.php?M=3643070&C=&S=483&L=80&N=318



Dear Dr. Xiang-Zhen Kong,

The International Journal of Negative Results welcomes all types of
articles such as original research, review, case-report, editorial,
short-communication, Letter to the Editor, etc.
Author can submit the manuscript to info@oap-cancer.org or upload
here http://oap-cancer.org/cfp2/link.php?M=3643070&N=483&L=380&F=T

Original research articles of the type - review, case-report,
editorial, short-communication, Letter to the Editor, etc., will
be provided 30% waiver on APC

To avail, this waiver, send the below token with your submission.

IIJNR3FEB15OAP

Please find our APC listed here, according to World Bank
classification

http://oap-cancer.org/cfp2/link.php?M=3643070&N=483&L=510&F=T

Call for papers 2018

Paper Submission Deadline: February 15, 2018

Complete information regarding IJNR be found below:

[1]Journal page:
http://oap-cancer.org/cfp2/link.php?M=3643070&N=483&L=511&F=T

[2]Instructions for Author:
http://oap-cancer.org/cfp2/link.php?M=3643070&N=483&L=512&F=T

[3]Scope: http://oap-cancer.org/cfp2/link.php?M=3643070&N=483&L=513&F=T

[4]Editorial Board:
http://oap-cancer.org/cfp2/link.php?M=3643070&N=483&L=514&F=T

[5]Membership link:
http://oap-cancer.org/cfp2/link.php?M=3643070&N=483&L=515&F=T

Thank you for reading. We await your submission.

With warm regards

John Abraham
Editorial Office
OAP 616 Corporate Way,
Suite 2-6158 Valley Cottage, NY 10989
United States
http://oap-cancer.org/cfp2/link.php?M=3643070&N=483&L=394&F=T
info@oap-cancer.org






To stop receiving these
emails:http://oap-cancer.org/cfp2/unsubscribe.php?M=3643070&C=&L=80&N=483
http://oap-cancer.org/cfp2/unsubscribe.php?M=3643070&C=&L=80&N=483
Unsubscribe me from this list

--b1_1148759d27530eb33e9fd06fdfffa2ff
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: 8bit
X-Microsoft-Exchange-Diagnostics:
	1;MAXPR0101MB2074;27:l4HdicTMorxMZZtz3RgaenxZRwEBXkziNmrcqToWYnbpUKNtQgnNBFuoDCWFWdvhK1TCppQjakTVfwYHKwk2mWyioQlK11W2BgACRbsW7rPoPkYvBCw35p7XyyrT6Nw9
X-Microsoft-Antispam-Mailbox-Delivery:
	abwl:0;wl:0;pcwl:0;kl:0;iwl:0;dwl:0;dkl:0;rwl:0;ex:0;auth:1;dest:J;ENG:(400001000128)(400125000095)(5062000261)(5061607266)(5061608174)(4900095)(4920089)(6375004)(4950112)(4990090)(9140004);RF:JunkEmail;OFR:SpamFilterAuthJ;
X-Message-Info:
	qoGN4b5S4ypJwnJu3iy0cITO4m4TF4G1iEJr/GiYirqQOvAOk0UD0WVgw5dQBZRVjO6+G/rLYenrurvYZN/4LKS0uJVQC6yiS6vrZ7TJ81ygDlgNeQGSYe03cXUbF6hs3V8hc5f1KPuMhiymubJxIB2Rf2KrCYQt7riTYUKykydZX3+3TbkvIu57rdWFBf156ug28TbMLYpvgME6ldPoew==
X-Message-Delivery: Vj0xLjE7dXM9MDtsPTA7YT0wO0Q9MjtHRD0yO1NDTD02
X-Microsoft-Antispam-Message-Info:
	SFGZnED32XPIgPtBMdFbeUfgtANq/DLxzJcssKqhL2ql4NnZnrvI0Tl64W8jYfD+RT9W8Ysw1yS9eIHt82/YLlfjoIz7vvjUm13ZAeu5HAjULDt5nU9Qg90U5P6cCuM0BK3oF7549IXyQgw7xk407UFHEASP2gTFeFV8Z+rZemqDnDgv9NI2hxMt+vLbIbSJUWDhV5ECVf1ZS4O/8WSzN30R9XmacM7+Wnw4rVC5OPztcgjYC3CjVs2mp9e36VwD6LTH0fuwXtdgpm5yxM7zDA==

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml"><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<title>IJNR</title>
</head>
<body>
<table border="0" align="center" style="width: 600px;">
<tbody>
<tr>
<td>
<p>Dear Dr. Xiang-Zhen Kong,</p>
The International Journal of Negative Results welcomes all types of
articles such as original research, review, case-report, editorial,
short-communication, Letter to the Editor, etc.
<p>Author can submit the manuscript to <a href="mailto:info@oap-cancer.org" target="_blank">info@oap-cancer.org</a> or upload here <a href="http://oap-cancer.org/cfp2/link.php?M=3643070&amp;N=483&amp;L=380&amp;F=H" target="_blank">http://oap-cancer.org/manuscriptzone/</a></p>
<p>Original research articles of the type - review, case-report, editorial,
short-communication, Letter to the Editor, etc., will be provided 30%
waiver on APC</p>
<p>To avail, this waiver, send the below token with your submission.</p>
<p>IIJNR3FEB15OAP</p>
<p>Please find our APC listed here, according to World Bank
classification</p>
<p><a href="http://oap-cancer.org/cfp2/link.php?M=3643070&amp;N=483&amp;L=510&amp;F=H" target="_blank">http://oap-cancer.org/journal/ijnr/article-processing-charges</a></p>
<p>Call for papers 2018</p>
<p>Paper Submission Deadline: February 15, 2018</p>
<p>Complete information regarding IJNR be found below:</p>
<p>[1]Journal page: <a href="http://oap-cancer.org/cfp2/link.php?M=3643070&amp;N=483&amp;L=511&amp;F=H" target="_blank">http://oap-cancer.org/journal/ijnr</a></p>
<p>[2]Instructions for Author: <a href="http://oap-cancer.org/cfp2/link.php?M=3643070&amp;N=483&amp;L=512&amp;F=H" target="_blank">http://oap-cancer.org/journal/ijnr/instructions-for-Author</a></p>
<p>[3]Scope: <a href="http://oap-cancer.org/cfp2/link.php?M=3643070&amp;N=483&amp;L=513&amp;F=H" target="_blank"> http://oap-cancer.org/journal/ijnr/aim-and-scope</a></p>
<p>[4]Editorial Board: <a href="http://oap-cancer.org/cfp2/link.php?M=3643070&amp;N=483&amp;L=514&amp;F=H" target="_blank">http://oap-cancer.org/journal/ijnr/editorial-board</a></p>
<p>[5]Membership link: <a href="http://oap-cancer.org/cfp2/link.php?M=3643070&amp;N=483&amp;L=515&amp;F=H" target="_blank">http://oap-cancer.org/journal/ijnr/membership</a></p>
<p>Thank you for reading. We await your submission.</p>
<p>With warm regards<br> <br>John Abraham<br>Editorial Office<br>OAP 616 Corporate Way,<br>Suite 2-6158 Valley Cottage, NY 10989<br>United States<br><a href="http://oap-cancer.org/cfp2/link.php?M=3643070&amp;N=483&amp;L=387&amp;F=H" target="_blank">http://www.oap-cancer.org</a><br><a href="mailto:info@oap-cancer.org" target="_blank">info@oap-cancer.org</a></p>
</td>
</tr>
</tbody>
</table>
<br><a href="http://oap-cancer.org/cfp2/unsubscribe.php?M=3643070&amp;C=&amp;L=80&amp;N=483">Unsubscribe
me from this list</a><img src="http://oap-cancer.org/cfp2/open.php?M=3643070&amp;L=80&amp;N=483&amp;F=H&amp;image=.jpg" height="1" width="10"></body>
</html>

--b1_1148759d27530eb33e9fd06fdfffa2ff--

